AKT/GSK-3 β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation
ConclusionsOur study identified the AKT/GSK-3 β/β-catenin axis as a critical mediator of EPO-induced glioma proliferation and further provided a clinically significant dimension to the biology of EPO.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Biology | Brain | Brain Tumor | Cancer | Cancer & Oncology | Chemistry | Glioma | Neurology | Study